Syntagon is a leading Scandinavia-based drug development partner. We develop your compound from lead optimization to phase II clinical trials using the latest technology and equipment combined with a solid quality system.

Our aim is to be the best partner in the biotechnology and pharmaceutical industries – no matter where your company is based. This means providing you with a comprehensive package, delivered on time and on budget.

Over the years, Syntagon has received many awards including the DI Gazella award for one of the fastest growing companies in Scandinavia. More importantly, over one hundred biotechnology and pharmaceutical clients have selected Syntagon for their pre-clinical and clinical development programs.